Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trisha R Berger

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Current Opinion in Immunology|March 22, 2021
Mechanisms of response and resistance to CAR T cell therapiesTrisha R Berger, Marcela V Maus
Med (New York, N.Y.)|August 13, 2022
Understanding CAR T cell-tumor interactions: Paving the way for successful clinical outcomesFelix Korell, Trisha R Berger, Marcela V Maus
Cell Reports. Medicine|September 13, 2025
CAR-T cells in solid tumors: Challenges and breakthroughsGiulia Escobar, Trisha R Berger, Marcela V Maus
European Journal of Immunology|December 31, 2022
Four challenges to CAR T cells breaking the glass ceilingStefanie R Bailey, Trisha R Berger, Charlotte Graham, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 12, 2022
Differential T-Cell Immunity to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in mRNA-1273- and BNT162b2-Vaccinated IndividualsKathleen M E Gallagher, Mark B Leick, Rebecca C Larson, et al.
Biorxiv : the Preprint Server for Biology|May 11, 2021
SARS -CoV-2 T-cell immunity to variants of concern following vaccinationKathleen M E Gallagher, Mark B Leick, Rebecca C Larson, et al.
Blood Advances|February 13, 2026
Ibrutinib exposure correlates with improved efficacy of CAR T cells in patients with mantle cell lymphomaEli P Darnell, Kathleen M E Gallagher, Justyna Kanska, et al.
Blood Advances|February 24, 2026
Ibrutinib exposure correlates with improved efficacy of CAR T cells in patients with mantle cell lymphomaEli P Darnell, Kathleen M E Gallagher, Justyna Kanska, et al.
Nature Communications|December 10, 2025
Tuning CAR-T cells by targeting cancer-associated glycan in pancreatic cancerSangwoo Park, Cassidy E Ho, Eli P Darnell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2025
Ibrutinib and PD-1 blockade potentiate mesothelin-targeting CAR-T cell therapy in preclinical models of pancreatic cancerAlexander Armstrong, Graziella van der Plancke, Sae Nishiguchi, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Current Opinion in Immunology|March 22, 2021
Mechanisms of response and resistance to CAR T cell therapiesTrisha R Berger, Marcela V Maus
Med (New York, N.Y.)|August 13, 2022
Understanding CAR T cell-tumor interactions: Paving the way for successful clinical outcomesFelix Korell, Trisha R Berger, Marcela V Maus
Cell Reports. Medicine|September 13, 2025
CAR-T cells in solid tumors: Challenges and breakthroughsGiulia Escobar, Trisha R Berger, Marcela V Maus
European Journal of Immunology|December 31, 2022
Four challenges to CAR T cells breaking the glass ceilingStefanie R Bailey, Trisha R Berger, Charlotte Graham, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 12, 2022
Differential T-Cell Immunity to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in mRNA-1273- and BNT162b2-Vaccinated IndividualsKathleen M E Gallagher, Mark B Leick, Rebecca C Larson, et al.
Biorxiv : the Preprint Server for Biology|May 11, 2021
SARS -CoV-2 T-cell immunity to variants of concern following vaccinationKathleen M E Gallagher, Mark B Leick, Rebecca C Larson, et al.
Blood Advances|February 13, 2026
Ibrutinib exposure correlates with improved efficacy of CAR T cells in patients with mantle cell lymphomaEli P Darnell, Kathleen M E Gallagher, Justyna Kanska, et al.
Blood Advances|February 24, 2026
Ibrutinib exposure correlates with improved efficacy of CAR T cells in patients with mantle cell lymphomaEli P Darnell, Kathleen M E Gallagher, Justyna Kanska, et al.
Nature Communications|December 10, 2025
Tuning CAR-T cells by targeting cancer-associated glycan in pancreatic cancerSangwoo Park, Cassidy E Ho, Eli P Darnell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2025
Ibrutinib and PD-1 blockade potentiate mesothelin-targeting CAR-T cell therapy in preclinical models of pancreatic cancerAlexander Armstrong, Graziella van der Plancke, Sae Nishiguchi, et al.
Pageof 3